BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Allogeneic mesenchymal bone marrow cells: Phase I/II started

Stemedica began an open-label, U.S. Phase I/II trial to evaluate a single dose of IV allogeneic mesenchymal bone marrow cells in...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >